Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.59 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CPB1 | P15086 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6411042 | 0.89 | ALDH1A1 (0.66) | ALDH1A1KMT2AMEN1ALOX15TSHR | |
| SCHEMBL6404088 | 0.89 | ALDH1A1 (0.78) | ALDH1A1KMT2AMEN1ALOX15TSHR | |
| SCHEMBL6404073 | 0.83 | ALDH1A1 (0.63) | HTTALDH1A1KMT2AMEN1MAPK1 | |
| SCHEMBL6404787 | 0.82 | CPB1 (0.64) | HTTALDH1A1KMT2AMEN1ALOX15 | |
| SCHEMBL4208335 | 0.82 | ALDH1A1 (0.77) | ALDH1A1KMT2AMEN1ALOX15TSHR | |
| SCHEMBL6405226 | 0.81 | TP53 (0.56) | ALDH1A1KMT2AMEN1ALOX15TSHR | |
| SCHEMBL6402175 | 0.81 | ALDH1A1 (0.60) | HTTALDH1A1KMT2AMEN1TSHR | |
| SCHEMBL6404742 | 0.79 | LMNA (0.58) | ALDH1A1KMT2AMEN1TSHRMAPK1 | |
| SCHEMBL5423806 | 0.78 | ALDH1A1 (0.64) | HTTALDH1A1KMT2AMEN1ALOX15 | |
| SCHEMBL3300655 | 0.75 | ALPG (0.53) | HTTALDH1A1KMT2AMEN1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | AGRIUS GROUP, LLC. | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | ABCG2, ATP5ME, DNTT | HTT 2113/4885ALDH1A1 720/4885KMT2A 2263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.